Phase 1 Cancer Vaccine Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Solid TumorsAdvanced CancerRecurrent Cancer+2 more

Seqker Biosciences, Inc.10 enrolled2 locationsNCT07002203

Recruiting

Phase 1

a Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid Tumors

Advanced Solid TumorCancer VaccinePolyphenols

Xingchen Peng9 enrolled1 locationNCT06878612